The hybridization capture-based approach utilized in this assay from Twist Bioscience and Biotia maximizes the number of genetic variants identified, where other sequencing methods may miss mutations in certain regions.
Read More
FDA has created a page on its website devoted to providing information about the impact of SARS-CoV-2 viral mutations on covid-19 tests, including recommendations for clinical laboratory staff.
Read More
In addition to its ability to detect SARS-CoV-2 even when it mutates, the VaNGuard test can be used on crude patient samples in a clinical setting without the need for RNA purification, and yields results in 30 minutes.
Read More
The high-performing qPCR system’s simplified, efficient workflow minimizes steps to deliver quality results in as little as 30 minutes.
Read More
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Read More